I’ve received one of AMD’s first official AI developer boxes for testing, and it’s an impressive piece of AI hardware with a ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...